STOCK TITAN

Auna Launches the First Integrated Oncology Insurance in Mexico

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Auna S.A. (NYSE: AUNA) has launched OncoSalud, the first integrated oncology insurance in Mexico, through its hospital network in Monterrey. This product, priced at an average of USD 40 per month, offers coverage up to USD 0.5 million annually for cancer prevention, detection, and treatment. It's designed for families with members up to 70 years old without pre-existing oncological conditions.

OncoSalud leverages Auna's 35 years of experience in Peru and Colombia, focusing on prevention and early detection with free preventive check-ups and diagnostic exams. The company estimates a total addressable market of up to 14 million people in Mexico, where cancer is the third leading cause of mortality. This initiative aims to transform access to oncology treatments and improve healthcare accessibility across the region.

Positive
  • Launch of OncoSalud, the first integrated oncology insurance in Mexico
  • Attractive pricing at USD 40 per month with coverage up to USD 0.5 million annually
  • Free preventive check-ups and diagnostic exams for policyholders
  • Leveraging 35 years of experience from Peru and Colombia
  • Estimated total addressable market of up to 14 million people in Mexico
Negative
  • None.

Auna's introduction of the first integrated oncology insurance in Mexico is a significant step for the healthcare sector in the region. This insurance product offers a comprehensive approach that includes prevention, early detection and treatment of cancer, which is essential given that cancer is the third leading cause of mortality in Mexico. By offering preventive check-ups and diagnostic exams free of charge, Auna is addressing a critical gap in the healthcare system, promoting early intervention, which is important for improving patient outcomes.

The average cost of USD 40 per month for coverage that includes up to USD 0.5 million in annual insured amount is quite competitive. This makes it accessible to a broad demographic, potentially increasing the uptake of such insurance and fostering a culture of preventive healthcare. Importantly, the use of their established protocols from Peru and Colombia, which have led to high survivor rates, adds credibility and value to the insurance product. This indicates that Auna is leveraging its extensive experience and research capabilities to provide high-quality oncology care in Mexico.

From a financial perspective, Auna's expansion into the Mexican market with their integrated oncology insurance product presents a strategic growth opportunity. The potential market of up to 14 million people indicates substantial room for revenue growth. Assuming a conservative penetration rate, the financial upside can be significant. The pricing at USD 40 per month is affordable, positioning Auna favorably against competitors and making their offering financially attractive to the target demographic.

Moreover, the operational integration through their hospital network in Monterrey could lead to efficiencies and cost savings, enhancing profitability. The historical success of similar products in Peru and Colombia suggests a proven business model that can be replicated in Mexico. However, investors should consider the potential risks such as market adoption, regulatory hurdles and execution challenges in a new market environment.

The product offers access to prevention and early detection of cancer, which is the third leading cause of mortality in the country.

MONTERREY, Mexico--(BUSINESS WIRE)-- Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the launch of the first oncology insurance in Mexico, fully integrated through its hospital network in Monterrey, Nuevo Leon.

Auna's integrated oncological insurance addresses the unmet needs of families and patients for cancer prevention, detection, and treatment coverage. The product, named after its successful predecessors in Peru, “OncoSalud”, covers the latest medical guidelines and protocols, as well as technology, within its Monterrey hospital network. OncoSalud benefits from over 35 years of product experience in Peru alongside outstanding oncology research capabilities in Colombia that have resulted in first-world survivor rates for its cancer patients.

The insurance product is tailored for families with members aged 70 years and younger without pre-existing oncological conditions. OncoSalud has been attractively priced at USD 40 per month on average, and policyholders benefit from an annual insured amount of up to USD 0.5 million. OncoSalud is well regarded for its focus on prevention and early detection, thus preventive check-ups and related diagnostic exams are free to policyholders.

“We are thrilled to reach this milestone after over 35 years of developing our integrated insurance products and services in Peru and Colombia,” said Suso Zamora, Chairman of the Board and President of Auna. “Auna has become a very relevant player in high complexity oncology in the cities we serve, and we believe this new product is a natural extension of what we already offer which impacts so positively the families and patients we cover. We are certain we will transform access to oncology treatments for Mexican communities of patients and healthcare providers alike.” He further remarked: “We aim to provide healthcare accessibility in the region, and estimate the total addressable market for this insurance product in Mexico is up to 14 million people who would benefit from our research, treatment protocols and world-class medical capabilities.”

Sven Boes, Executive Vice President of Health Services added, “We are excited to launch our oncological protection insurance to the market, marking a significant milestone in our ongoing commitment to improving the lives of cancer patients and providing early-stage disease care. This product aims not only to alleviate physical symptoms but also to provide comprehensive support addressing the emotional and physical needs of patients during their cancer journey. Today we cover over a million with insurance products that are accessible and deliver best in class services. Last year, we treated over 40,000 cancer patients in the region.”

Auna aims to promote prevention and early detection through its innovative insurance product, underscoring its commitment to enhancing healthcare accessibility and transforming healthcare delivery across the region. With cancer ranking as Mexico's third leading cause of mortality, and a substantial portion of cases preventable or potentially diagnosable in time, this initiative seeks to empower individuals with proactive measures for better health outcomes.

About Auna

Auna is a Latin American healthcare company with operations in Mexico, Peru and Colombia, prioritizing prevention and concentrating on high complexity diseases that contribute the most to healthcare expenditures. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish Speaking Americas. Founded in 1989, Auna has built one of Latin America’s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of March 31, 2024, Auna’s network included 31 healthcare network facilities, consisting of hospitals, outpatient, prevention and wellness facilities with a total of 2,308 beds, and 1.2 million healthcare plans.

For more information visit www.aunainvestors.com.

Forward Looking Statements

This press release contains forward-looking statements. The forward-looking statements contained herein include statements about the total addressable market for Auna’s insurance product in Mexico, among others. These expectations may or may not be realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, Auna’s business and operations involve numerous risks and uncertainties, many of which are beyond the control of Auna, which could result in Auna’s expectations not being realized or otherwise materially affect the financial condition, results of operations and cash flows of Auna. Among the risks and uncertainties that could cause actual results to differ from those described in forward-looking statements are if third-party or internally generated data prove to be inaccurate or Auna makes errors in its assumptions based on that data. Additional information relating to the uncertainties affecting Auna’s business is contained in its filings with the Securities and Exchange Commission. The forward-looking statements are made only as of the date hereof, and Auna does not undertake any obligation to and expressly disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date such statements were made, or to reflect the occurrence of unanticipated events.

Investor Relations

contact@aunainvestors.com

Source: Auna S.A.

FAQ

What is OncoSalud and when did Auna (NYSE: AUNA) launch it in Mexico?

OncoSalud is the first integrated oncology insurance in Mexico, launched by Auna (NYSE: AUNA) in 2023. It offers coverage for cancer prevention, detection, and treatment through Auna's hospital network in Monterrey.

How much does Auna's OncoSalud insurance cost and what is the coverage limit?

OncoSalud is priced at an average of USD 40 per month, with an annual insured amount of up to USD 0.5 million for policyholders.

Who is eligible for Auna's OncoSalud insurance in Mexico?

OncoSalud is tailored for families with members aged 70 years and younger without pre-existing oncological conditions.

What unique features does Auna's OncoSalud offer to policyholders?

OncoSalud offers free preventive check-ups and related diagnostic exams, focusing on prevention and early detection of cancer. It also benefits from Auna's 35 years of product experience and oncology research capabilities.

What is the estimated market size for Auna's OncoSalud in Mexico?

Auna estimates the total addressable market for OncoSalud in Mexico to be up to 14 million people who could benefit from their research, treatment protocols, and medical capabilities.

Auna S.A.

NYSE:AUNA

AUNA Rankings

AUNA Latest News

AUNA Stock Data

502.64M
30.00M
20.46%
37.93%
0.4%
Medical Care Facilities
Healthcare
Link
United States of America
Luxembourg